Two derivatives (DKP-071 and DKP-073) have been previously tested in melanoma and cutaneous T-cell lymphoma cells, where they induced apoptosis in combination with the death ligand TRAIL and affected cell viability [25,47]. The gene discussed is TNFSF10; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.